279 related articles for article (PubMed ID: 26064932)
1. Preclinical Murine Models for Lung Cancer: Clinical Trial Applications.
Kellar A; Egan C; Morris D
Biomed Res Int; 2015; 2015():621324. PubMed ID: 26064932
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
Merk J; Rolff J; Becker M; Leschber G; Fichtner I
Eur J Cardiothorac Surg; 2009 Sep; 36(3):454-9. PubMed ID: 19502076
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapies for non-small cell lung cancer.
Dempke WC; Suto T; Reck M
Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
[TBL] [Abstract][Full Text] [Related]
4. Advances in treatment of lung cancer with targeted therapy.
Cagle PT; Chirieac LR
Arch Pathol Lab Med; 2012 May; 136(5):504-9. PubMed ID: 22540298
[TBL] [Abstract][Full Text] [Related]
5. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
[TBL] [Abstract][Full Text] [Related]
6. Trial offers new model for drug development.
Cancer Discov; 2014 Mar; 4(3):266-7. PubMed ID: 24596189
[TBL] [Abstract][Full Text] [Related]
7. From mice to men: GEMMs as trial patients for new NSCLC therapies.
Hayes SA; Hudson AL; Clarke SJ; Molloy MP; Howell VM
Semin Cell Dev Biol; 2014 Mar; 27():118-27. PubMed ID: 24718320
[TBL] [Abstract][Full Text] [Related]
8. New molecular targeted therapies integrated with radiation therapy in lung cancer.
Provencio M; Sánchez A; Garrido P; Valcárcel F
Clin Lung Cancer; 2010 Mar; 11(2):91-7. PubMed ID: 20199974
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant treatment of stage IB NSCLC: the problem of stage subset heterogeneity.
Calhoun R; Jablons D; Lau D; Gandara DR
Oncology (Williston Park); 2008 Apr; 22(5):511-6; discussion 516, 521-3. PubMed ID: 18533401
[TBL] [Abstract][Full Text] [Related]
10. Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer.
Hammer S; Sommer A; Fichtner I; Becker M; Rolff J; Merk J; Klar U; Hoffmann J
Clin Cancer Res; 2010 Mar; 16(5):1452-65. PubMed ID: 20179216
[TBL] [Abstract][Full Text] [Related]
11. ALK-targeted therapy for lung cancer: ready for prime time.
Husain H; Rudin CM
Oncology (Williston Park); 2011 Jun; 25(7):597-601. PubMed ID: 21888258
[TBL] [Abstract][Full Text] [Related]
12. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
Crawford J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
[TBL] [Abstract][Full Text] [Related]
13. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
14. Topotecan in small cell lung cancer.
Schiller JH
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-27-S20-33. PubMed ID: 9425958
[TBL] [Abstract][Full Text] [Related]
15. Systemic therapy for lung cancer brain metastases: a rationale for clinical trials.
Oh Y; Stewart DJ
Oncology (Williston Park); 2008 Feb; 22(2):168-78; discussion 178, 183, 188 passim. PubMed ID: 18409662
[TBL] [Abstract][Full Text] [Related]
16. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
17. Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts.
Ambrogio C; Carmona FJ; Vidal A; Falcone M; Nieto P; Romero OA; Puertas S; Vizoso M; Nadal E; Poggio T; Sánchez-Céspedes M; Esteller M; Mulero F; Voena C; Chiarle R; Barbacid M; Santamaría D; Villanueva A
Cancer Res; 2014 Nov; 74(21):5978-88. PubMed ID: 25217522
[TBL] [Abstract][Full Text] [Related]
18. Practical use of advanced mouse models for lung cancer.
Safari R; Meuwissen R
Methods Mol Biol; 2015; 1267():93-124. PubMed ID: 25636466
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies in lung cancer.
Wang Y; Deng G; Liu X; Cho WC
Expert Opin Biol Ther; 2013 Feb; 13(2):209-26. PubMed ID: 23240766
[TBL] [Abstract][Full Text] [Related]
20. ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development.
Scagliotti G; Stahel RA; Rosell R; Thatcher N; Soria JC
Eur J Cancer; 2012 May; 48(7):961-73. PubMed ID: 22397764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
